Med-X (MXRX) 3-Year RORE % : 0.00% (As of Dec. 2022)


What is Med-X 3-Year RORE %?

Med-X MXRX 3-Year RORE % is 0.00 as of Dec. 2022.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Med-X does not have enough data to calculate 3-Year RORE %.

Med-X  (NAS:MXRX) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.

Med-X 3-Year RORE % Related Terms

Med-X 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Med-X's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med-X 3-Year RORE % Chart

Med-X Annual Data
Trend Dec20 Dec21 Dec22
3-Year RORE %
0.00 0.00 0.00

Med-X Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22
3-Year RORE % 0.00 0.00 0.00 0.00 0.00

MXRX vs : 3-Year RORE % Comparison

For the Household & Personal Products subindustry, Med-X's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Med-X 3-Year RORE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Med-X's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Med-X's 3-Year RORE % falls into.


Med-X 3-Year RORE % Calculation

Med-X's 3-Year RORE % for the quarter that ended in Dec. 2022 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2022 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 0.00 mean?
Med-X (MXRX) has a 3-Year RORE % of 0.00 as of Dec. 2022. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Med-X and its competitors.
Is Med-X's 3-Year RORE % too high?
Med-X's current 3-Year RORE % is 0.00.
How does Med-X's 3-Year RORE % compare to ?
Med-X's 3-Year RORE % of 0.00 can be compared against companies in the Consumer Packaged Goods industry. The industry median 3-Year RORE % is 6.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Consumer Packaged Goods company?
The median 3-Year RORE % among Consumer Packaged Goods companies is 6.02, based on 1,827 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Med-X and its competitors. For the Consumer Packaged Goods industry, the median 3-Year RORE % is 6.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med-X's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Med-X (MXRX), the current 3-Year RORE % is 0.00 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med-X Business Description

Comparable Companies
Address 8236 Remmet Avenue, Canoga Park, CA, USA, 91304
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.